home / stock / aemd / aemd quote
Last: | $1.53 |
---|---|
Change Percent: | 0.13% |
Open: | $1.51 |
Close: | $1.53 |
High: | $1.53 |
Low: | $1.51 |
Volume: | 619 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.53 | $1.51 | $1.53 | $1.53 | $1.51 | 619 | 04-24-2024 |
$1.5119 | $1.5 | $1.5119 | $1.55 | $1.5 | 17,052 | 04-23-2024 |
$1.48 | $1.47 | $1.48 | $1.48 | $1.421 | 1,438 | 04-22-2024 |
$1.46 | $1.46 | $1.46 | $1.48 | $1.4276 | 18,493 | 04-19-2024 |
$1.415 | $1.425 | $1.415 | $1.4452 | $1.415 | 2,296 | 04-18-2024 |
$1.42 | $1.43 | $1.42 | $1.4889 | $1.35 | 15,388 | 04-17-2024 |
$1.4399 | $1.4501 | $1.4399 | $1.46 | $1.43 | 8,071 | 04-16-2024 |
$1.45 | $1.48 | $1.45 | $1.48 | $1.45 | 2,339 | 04-15-2024 |
$1.5101 | $1.56 | $1.5101 | $1.56 | $1.46 | 13,713 | 04-12-2024 |
$1.56 | $1.62 | $1.56 | $1.63 | $1.55 | 6,865 | 04-11-2024 |
$1.64 | $1.6893 | $1.64 | $1.6893 | $1.64 | 2,890 | 04-10-2024 |
$1.657 | $1.65 | $1.657 | $1.6959 | $1.64 | 6,018 | 04-09-2024 |
$1.68 | $1.7 | $1.68 | $1.715 | $1.66 | 13,802 | 04-08-2024 |
$1.75 | $1.77 | $1.75 | $1.77 | $1.6801 | 7,232 | 04-05-2024 |
$1.71 | $1.71 | $1.71 | $1.7365 | $1.7 | 3,666 | 04-04-2024 |
$1.73 | $1.76 | $1.73 | $1.76 | $1.73 | 7,841 | 04-03-2024 |
$1.76 | $1.73 | $1.76 | $1.77 | $1.69 | 13,030 | 04-02-2024 |
$1.73 | $1.68 | $1.73 | $1.76 | $1.67 | 3,787 | 04-01-2024 |
$1.68 | $1.74 | $1.68 | $1.74 | $1.67 | 14,918 | 03-29-2024 |
$1.68 | $1.74 | $1.68 | $1.74 | $1.67 | 14,918 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier® Blood Filtration System...
2024-02-21 09:30:00 ET SAN DIEGO - February 21, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that it entered into a Materia...
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices PR Newswire Aethlon Medical Will Perform Pre-Clinical Studies to Explore Potential Synergies With its First-in-Class Hemopurifier ® Blood Filtration...